The wisdom of crowds
A recent paper out of Manolis Kellis' group shows the wisdom of crowds when it comes to selecting methods for analyzing gene regulatory networks.
Search Stories
One-two punch knocks out aggressive breast cancer cells
New MIT study shows that staggered delivery of cancer drugs is far more effective than administering them at the same time.
Targeted nanoparticles show success in clinical trials
Tiny particles designed to home in on cancer cells achieve tumor shrinkage at lower doses than traditional chemotherapy.
Brothers of Phi Beta Epsilon win first annual FSILG&D Community Service Challenge Photo Contest
Students showcase photos of living group's community service work
The sweet color of pink
Breast cancer awareness and desserts offer two great reasons for MIT students to come together.
Tumor cells go against the flow
Microfluidic model helps explain how fluid’s flow in bodily tissue influences tumor cell migration.
Study explains why men are at higher risk for stomach cancer
MIT researchers show how estrogen protects women from the gastric inflammation that can lead to cancer.
Turning off cancer’s growth signals
Biological engineers’ new approach to shutting down cell division could lead to new cancer drugs.
The past, present and future of cancer
Researchers gather to discuss the state of their field and the potential for new treatments.
Anne Mayes, former materials science professor, dies at 46
'Fiercely dedicated to MIT students,' she established fellowship prior to leaving the Institute.
Delivering a potent cancer drug with nanoparticles can lessen side effects
The new nanoparticle, which delivers the drug in a form activated when it reaches its target, also treats tumors more effectively than the unadorned drug in mice.
Using the body’s own defenses to combat cancer
By engineering T cells to attack tumors, researchers hope to add a new weapon to their cancer-fighting arsenal.
A better way to target tumors
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.
MIT Medical promotes employee mammograms
No referral or copay for female employees between 40 and 70 who are enrolled in any MIT-sponsored health-insurance plan.